Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasm, Plasma Cell

Clinical trial condition

Neoplasm, Plasma Cell

Explore clinical trials studying Neoplasm, Plasma Cell. Study availability and eligibility vary by location and protocol.

4 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Neoplasm, Plasma Cell trial results

Recruiting

BCMA-Targeted CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease

NCT04271644

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: 920th Hospital of Joint Logistics Support Force Kunming, Yunnan, China

View Trial Details

Recruiting

a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease

NCT04776330

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: 920th Hospital of Joint Logistics Support Force Kunming, Yunnan, China

View Trial Details

Recruiting

A Study to Investigate Safety and Clinical Activity of Belantamab Mafodotin in Combination With Lenalidomide, Dexamethasone and Nirogacestat in Patients With Transplant Ineligible Newly Diagnosed Multiple Myeloma

NCT05573802

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Corneal Disease, +18 more
Locations: General Hospital of Athens "Alexandra", NKUA, Therapeutic Clinic Athens, Greece

Anticancer Hospital of Thessaloniki "Theageneio" Thessaloniki, Greece

View Trial Details

Completed

Impact of Chemotherapeutic Treatments in Patients Aged 75 Years and Over Treated for Lymphoid Hematological Malignancy

NCT05101759

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: University Hospital Toulouse Toulouse, France

View Trial Details